Most Patients Prefer Anti-Inflammatories Over Acetaminophen
March 10, 2000 (Minneapolis) -- People with chronic joint or muscle pain see
aspirin and other medications designed to reduce inflammation as more effective
than acetaminophen (Tylenol), according to a study published in a recent issue
of Arthritis & Rheumatism.
The study looked at a group of anti-inflammatories that are called
non-steroidal anti-inflammatory drugs, or NSAIDs, to distinguish them from the
powerful anti-anflammatory drugs corticosteroids. NSAIDs include aspirin and
ibuprofen as well as the newer Cox-2 inhibitors, which are prescription
Through mailed questionnaires, the researchers surveyed nearly 1,800
patients who had one of three diseases characterized by either joint or muscle
pain: osteoarthritis, rheumatoid arthritis, or fibromyalgia.
"There was a considerable and statistically significant preference for
NSAIDs compared with acetaminophen among the [three] groups of ? patients,"
the authors write. They say that this preference was found among all types of
patients studied, and was not altered by the severity of their diseases.
"If safety and cost are not issues, there would hardly ever be a reason to
recommend acetaminophen over NSAIDs, since patients generally preferred
NSAIDs," the authors say.
The American College of Rheumatology has recommended that people with these
conditions take acetaminophen before progressing to NSAIDs, study author
Frederick Wolfe, MD, tells WebMD. This is based on two concerns. First,
physicians have been concerned for some time about side effects on the stomach
and intestines associated with NSAIDs, including ulceration, bleeding,
perforation of the stomach, even death. Second, previous studies have shown
that acetaminophen and NSAIDs may be equally effective.
"Although an earlier study suggested that acetaminophen and NSAIDs were
equally effective ? I didn't see patients who thought they were equally
effective," Wolfe says. "The preference for NSAIDs held up across
disease categories, even when adverse reactions were considered." Wolfe is
a rheumatologist and clinical professor of medicine at the University of Kansas
in Wichita, where he is the director of the National Databank for Rheumatic
Diseases at the Arthritis Research Center Foundation.
Over 60% of the surveyed patients who had taken acetaminophen reported that
it was either not effective at all or only slightly effective. About the same
percentage thought that acetaminophen was less effective than NSAIDS, while
about 12% felt that that it was more effective.